These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 7333326)
41. The effect of age and sex on metabolism and urinary excretion of antipyrine. Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428 [TBL] [Abstract][Full Text] [Related]
42. [The use of the antipyrine test in assessing liver function in patients with insulin-dependent diabetes mellitus]. Khanina EV; Gorshteĭn ES; Michurina SP Probl Endokrinol (Mosk); 1990; 36(3):14-5. PubMed ID: 2395825 [TBL] [Abstract][Full Text] [Related]
43. Altered elimination of antipyrine in patients with acute viral hepatitis. Burnett DA; Barak AJ; Tuma DJ; Sorrell MF Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717 [TBL] [Abstract][Full Text] [Related]
46. [Evaluation of the functional status of hepatic microsomal enzymes in workers exposed to carbon dioxide and vinyl chloride by using the antipyrine test]. Lutz W; Stankiewicz A; Krajewska B Med Pr; 1987; 38(3):157-66. PubMed ID: 3118136 [TBL] [Abstract][Full Text] [Related]
47. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample. Loft S; Nielsen AJ; Borg BE; Poulsen HE Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365 [TBL] [Abstract][Full Text] [Related]
48. Variation of microsomal mixed function oxidase(s) and human lung cancer. Kellermann G; Jett JR; Luyten-Kellermann M; Moses HL; Fontana RS Cancer; 1980 Mar; 45(6):1438-42. PubMed ID: 7357525 [TBL] [Abstract][Full Text] [Related]
49. The use of antipyrine clearance to measure liver damage in psoriatic patients receiving methotrexate. Paramsothy J; Strange R; Sharif H; Collins M; Shaw P; Lawrence CM Br J Dermatol; 1988 Dec; 119(6):761-5. PubMed ID: 3203069 [TBL] [Abstract][Full Text] [Related]
50. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism. Rivière JH; Back DJ; Breckenridge AM; Howells RE Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153 [TBL] [Abstract][Full Text] [Related]
51. Impairment of hepatic drug metabolism in patients with acute viral hepatitis. Narang AP; Datta DV; Nath N; Mathur VS Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177 [TBL] [Abstract][Full Text] [Related]
52. Disposition of antipyrine and phenytoin correlated with age and liver volume in man. Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060 [TBL] [Abstract][Full Text] [Related]
53. The effect of fever on antipyrine metabolism in children. Forsyth JS; Moreland TA; Rylance GW Br J Clin Pharmacol; 1982 Jun; 13(6):811-5. PubMed ID: 7093111 [TBL] [Abstract][Full Text] [Related]
55. [Comparative study on the elimination of pindolol (visken) and antipyrin in patients with liver diseases]. Ohnhaus EE; Münch U; Meier J Schweiz Med Wochenschr; 1976 Dec; 106(49):1748-50. PubMed ID: 1013699 [TBL] [Abstract][Full Text] [Related]
56. Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance. Elin RJ; Vesell ES; Wolff SM Clin Pharmacol Ther; 1975 Apr; 17(4):447-57. PubMed ID: 1122686 [TBL] [Abstract][Full Text] [Related]